Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 43,564 | 0 |
| Cost of Goods | N/A | N/A | N/A | 4,843 | N/A |
| Gross Profit | N/A | N/A | N/A | 38,721 | N/A |
| Operating Expenses | 0 | 0 | 0 | 33,281 | 0 |
| Operating Income | N/A | N/A | N/A | 6,283 | N/A |
| Other Income | 0 | 0 | 0 | 6,509 | 0 |
| Pre-tax Income | 0 | 0 | 0 | 12,792 | 0 |
| Income Tax | N/A | N/A | N/A | 4,269 | N/A |
| Net Income Continuous | N/A | N/A | N/A | 8,523 | N/A |
| Net Income | $N/A | $N/A | $N/A | $8,523 | $N/A |
| EPS Basic Total Ops | N/A | N/A | N/A | 0.13 | N/A |
| EPS Basic Continuous Ops | N/A | N/A | N/A | 0.13 | N/A |
| EPS Diluted Total Ops | N/A | N/A | N/A | 0.13 | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | 0.13 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.01 | N/A | 0.06 | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $N/A | $8,346 | $N/A |